Literature DB >> 9590641

An international comparative study of total hip arthroplasty cost and practice patterns.

C M Metz1, A A Freiberg.   

Abstract

The cost of total hip arthroplasty (THA) was assessed on a worldwide basis, with specific information obtained regarding implant type, cost, manufacturer, fixation method, as well as other clinical related practices. One hundred and ten orthopaedic surgeons representing 30 countries and 6 continents responded to the questionnaire. The average number of THAs per year per surgeon was 75 (range, 2-300). Surgeons reported using all cemented components in 35% of THAs at an average cost of $1,536 (U.S. dollars). Uncemented components were used in 31% at an average cost of $2,674, and hybrid reconstructions in 34% at an average cost of $2,114. Almost half (44%) of the respondents stated that the hospital negotiated the type and price of the implants. Most surgeons (80%) indicated they were under pressure to decrease the cost of THA and 68% were under pressure to reduce the length of patients' hospital stay. When asked for recommended ways to reduce costs, 30% stated that negotiating a reduced implant price from the supplier was the most important measure. On a worldwide basis, there is tremendous variation in the cost and availability of implants. The reported cost for identical implants from a single manufacturer can vary as much as 700%. The comments of those responding are similar to the findings of surgeons here in the United States regarding cost containment and the role of reducing the length of hospital stay as well as negotiating reduced prosthesis and supply costs. The orthopaedic surgeon's practice pattern is a major determinant of total costs.

Entities:  

Mesh:

Year:  1998        PMID: 9590641     DOI: 10.1016/s0883-5403(98)90175-9

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

1.  Assessing the value of a total joint replacement.

Authors:  David B Bumpass; Ryan M Nunley
Journal:  Curr Rev Musculoskelet Med       Date:  2012-12

2.  Impact of the Medicare Short Stay Transfer Policy on patients undergoing major orthopedic surgery.

Authors:  John D FitzGerald; W John Boscardin; Bevra H Hahn; Susan L Ettner
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

3.  Early discharge and home intervention reduces unit costs after total hip replacement: results of a cost analysis in a randomized study.

Authors:  Eyjolfur Sigurdsson; Kristin Siggeirsdottir; Halldor Jonsson; Vilmundur Gudnason; Thorolfur Matthiasson; Brynjolfur Y Jonsson
Journal:  Int J Health Care Finance Econ       Date:  2008-06-21

4.  Can choices between alternative hip prostheses be evidence based? a review of the economic evaluation literature.

Authors:  Charlotte Davies; Paula Lorgelly; Ian Shemilt; Miranda Mugford; Keith Tucker; Alex Macgregor
Journal:  Cost Eff Resour Alloc       Date:  2010-10-29

5.  MRI as a problem-solving tool in unexplained failed total hip replacement following conventional assessment.

Authors:  Ciaran Johnston; Jennifer Kerr; Stephanie Ford; John O'byrne; Stephen Eustace
Journal:  Skeletal Radiol       Date:  2007-07-06       Impact factor: 2.199

6.  The aftermath of hip fracture: discharge placement, functional status change, and mortality.

Authors:  Suzanne E Bentler; Li Liu; Maksym Obrizan; Elizabeth A Cook; Kara B Wright; John F Geweke; Elizabeth A Chrischilles; Claire E Pavlik; Robert B Wallace; Robert L Ohsfeldt; Michael P Jones; Gary E Rosenthal; Fredric D Wolinsky
Journal:  Am J Epidemiol       Date:  2009-10-04       Impact factor: 4.897

7.  Profit-Influencing Factors in Orthopedic Surgery: An Analysis of Costs and Reimbursements.

Authors:  Felix Rohrer; Aresh Farokhnia; Hubert Nötzli; Frederik Haubitz; Tanja Hermann; Brigitta Gahl; Andreas Limacher; Jan Brügger
Journal:  Int J Environ Res Public Health       Date:  2022-04-04       Impact factor: 3.390

8.  Cemented, cementless, and hybrid prostheses for total hip replacement: cost effectiveness analysis.

Authors:  Mark Pennington; Richard Grieve; Jasjeet S Sekhon; Paul Gregg; Nick Black; Jan H van der Meulen
Journal:  BMJ       Date:  2013-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.